Navigation Links
SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
Date:3/2/2009

CHICAGO, March 2 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) and the American College of Obstetricians and Gynecologists (ACOG) have jointly developed a breast disease fellowship training program for gynecologic oncologists. Supported by a grant of $75,000 from ACOG, the program provides support for a gynecologic oncologist to complete a one-year fellowship training in the care and treatment of breast cancer and related disease.

"As experts in women's cancer care it seems only natural that interested gynecologic oncologists, who already possess an in-depth understanding of some women's cancers, should have the opportunity to obtain concentrated, advanced specialty training in the care and treatment of breast disease. This will allow those gynecologic oncologists the opportunity to provide care in more aspects of women's cancer care and pave the way for patients to get comprehensive cancer care in a single place," explained SGO President David G. Mutch, M.D. "Emerging data suggests that many diseases are best treated by those who have received specialized training, and the link between gynecologic cancers and breast cancers is clear. We are extremely grateful to ACOG for recognizing this important educational need. Together, we are confident this program will improve women's cancer care in the coming years."

"Breast cancer is the second leading cause of cancer death in US women. One out of every seven women will develop breast cancer in her lifetime," noted ACOG President Douglas H. Kirkpatrick, M.D. "We believe this fellowship is an important step forward in improving health care for women."

Applications will be accepted beginning this summer for the one-year fellowship, slated to begin in 2010. The process calls for both the prospective gynecologic oncology fellow and his/her institution to jointly submit an application. The program was designed to be flexible in nature, allowing the fellowship to be offered at a different institution each year, and afford a greater number of gynecologic oncology fellows interested in advanced training in breast disease the opportunity to apply, regardless of their current location.

"We are really excited to be able to offer this opportunity to interested gynecologic oncology fellows and to be at the forefront of creating what SGO and ACOG hope will evolve into a standardized method of specialty training in breast disease," concluded Dr. Mutch. "Our long-term goal is to be able to support numerous breast disease fellowships throughout the country that will in time have a dramatic influence on the care and treatment for women battling breast cancer."

The American College of Obstetricians and Gynecologists (ACOG) is the nation's leading group of professionals providing health care for women. As a private, voluntary, nonprofit organization, ACOG: serves as a strong advocate for quality health care for women; maintains the highest standards of clinical practice and continuing education of its members; promotes patient education and stimulates patient understanding of, and involvement in, medical care; and increases awareness among its members and the public of the changing issues facing women's health care. www.acog.org

The SGO is a national medical specialty organization of physicians who are trained in the comprehensive management of women with malignancies of the reproductive tract. Its purpose is to improve the care of women with gynecologic cancer by encouraging research, disseminating knowledge which will raise the standards of practice in the prevention and treatment of gynecologic malignancies, and cooperating with other organizations interested in women's health care, oncology and related fields. The Society's membership, totaling more than 1,230, is primarily comprised of gynecologic oncologists, as well as other related medical specialists including medical oncologists, radiation oncologists and pathologists. SGO members provide multidisciplinary cancer treatment including chemotherapy, radiation therapy, surgery and supportive care. More information on the SGO can be found at www.sgo.org.

    CONTACT:
    Susan Morris, SGO,
    312-235-4060
    Amanda Hall, ACOG,
    202-484-3321


'/>"/>
SOURCE Society of Gynecologic Oncologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
2. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
3. TissueGene Announces Regulatory Allowance to Initiate Phase IIa Study of TG-C in South Korea for Osteoarthritis of the Knee
4. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
5. Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer
6. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
7. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
8. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
9. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
10. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
11. Kensey Nash Announces IDE Submission for Cartilage Repair Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017 Non-alcoholic ... on the various drugs being developed for ... all the drugs that are in various ... The pipeline focuses on novel pharmacologic drugs ... stem cell therapies, recombinant proteins and RNA-based ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
Breaking Medicine Technology:
(Date:2/23/2017)... FL (PRWEB) , ... February 23, 2017 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – will return to the La Gorce Country Club in Miami Beach to ...
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss ... WE TV’s “Mama June: From Not to Hot,” which will begin airing on February ... Shannon, known to millions from the 2012 reality television series, “Here Comes Honey Boo ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO ... the National Institute for Health and Care Excellence (NICE) framework. The ... National Health Service (NHS) to search, order and purchase medical and healthcare-related content ...
(Date:2/23/2017)... ... 2017 , ... Pink Pig Publishing LLC announces the launch ... the world from different perspectives. By providing a place for people of all ... empathy, and find greater happiness. , "Our approach to structuring content is ...
(Date:2/23/2017)... NJ (PRWEB) , ... February 23, 2017 , ... ... the pre-eminent publication and community for those in the fight against cancer, has ... important in their success. HRA will release top-line findings in a webinar, ...
Breaking Medicine News(10 mins):